Works matching IS 03065251 AND DT 1985 AND VI 20 AND IP 5
1
- British Journal of Clinical Pharmacology, 1985, v. 20, n. 5, p. 511, doi. 10.1111/j.1365-2125.1985.tb05110.x
- Butler, RC;
- Goddard, DH;
- Higgens, CS;
- Hollingworth, P.;
- Pease, CT;
- Stodell, MA;
- Scott, JT
- Article
2
- British Journal of Clinical Pharmacology, 1985, v. 20, n. 5, p. 486, doi. 10.1111/j.1365-2125.1985.tb05103.x
- Article
3
- British Journal of Clinical Pharmacology, 1985, v. 20, n. 5, p. 500, doi. 10.1111/j.1365-2125.1985.tb05107.x
- Blain, PG;
- Mucklow, JC;
- Rawlins, MD;
- Roberts, DF;
- Routledge, PA;
- Shand, DG
- Article
4
- British Journal of Clinical Pharmacology, 1985, v. 20, n. 5, p. 447, doi. 10.1111/j.1365-2125.1985.tb05095.x
- Article
5
- British Journal of Clinical Pharmacology, 1985, v. 20, n. 5, p. 469, doi. 10.1111/j.1365-2125.1985.tb05099.x
- Riviere, JH;
- Back, DJ;
- Breckenridge, AM;
- Howells, RE
- Article
6
- British Journal of Clinical Pharmacology, 1985, v. 20, n. 5, p. 482, doi. 10.1111/j.1365-2125.1985.tb05102.x
- Article
7
- British Journal of Clinical Pharmacology, 1985, v. 20, n. 5, p. 497, doi. 10.1111/j.1365-2125.1985.tb05106.x
- Kemp, J.;
- Ilett, KF;
- Booth, J.;
- Hackett, LP
- Article
8
- British Journal of Clinical Pharmacology, 1985, v. 20, n. 5, p. 437, doi. 10.1111/j.1365-2125.1985.tb05094.x
- Silke, B.;
- Verma, SP;
- Frais, MA;
- Hafizullah, M.;
- Taylor, SH
- Article
9
- British Journal of Clinical Pharmacology, 1985, v. 20, n. 5, p. 463, doi. 10.1111/j.1365-2125.1985.tb05098.x
- Article
10
- British Journal of Clinical Pharmacology, 1985, v. 20, n. 5, p. 479, doi. 10.1111/j.1365-2125.1985.tb05101.x
- Wyk, M.;
- Sommers, DK;
- Steyn, AG
- Article
11
- British Journal of Clinical Pharmacology, 1985, v. 20, n. 5, p. 492, doi. 10.1111/j.1365-2125.1985.tb05105.x
- Hovi-Viander, M.;
- Kanto, J.;
- Scheinin, H.;
- Scheinin, M.
- Article
12
- British Journal of Clinical Pharmacology, 1985, v. 20, n. 5, p. 431, doi. 10.1111/j.1365-2125.1985.tb05093.x
- Harron, DW;
- Riddell, JG;
- Shanks, RG
- Article
13
- British Journal of Clinical Pharmacology, 1985, v. 20, n. 5, p. 507, doi. 10.1111/j.1365-2125.1985.tb05109.x
- Johnston, GD;
- Finch, MB;
- McNeill, JA;
- Shanks, RG
- Article
14
- British Journal of Clinical Pharmacology, 1985, v. 20, n. 5, p. 459, doi. 10.1111/j.1365-2125.1985.tb05097.x
- Richards, R.;
- Tattersfield, AE
- Article
15
- British Journal of Clinical Pharmacology, 1985, v. 20, n. 5, p. 475, doi. 10.1111/j.1365-2125.1985.tb05100.x
- Article
16
- British Journal of Clinical Pharmacology, 1985, v. 20, n. 5, p. 515, doi. 10.1111/j.1365-2125.1985.tb05111.x
- Article
17
- British Journal of Clinical Pharmacology, 1985, v. 20, n. 5, p. 489, doi. 10.1111/j.1365-2125.1985.tb05104.x
- Szawlowski, PW;
- Al-Safi, SA;
- Dooley, T.;
- Maddocks, JL
- Article
18
- British Journal of Clinical Pharmacology, 1985, v. 20, n. 5, p. 503, doi. 10.1111/j.1365-2125.1985.tb05108.x
- Article
19
- British Journal of Clinical Pharmacology, 1985, v. 20, n. 5, p. 453, doi. 10.1111/j.1365-2125.1985.tb05096.x
- Bonde, J.;
- Pedersen, LE;
- Bodtker, S.;
- Angelo, HR;
- Svendsen, TL;
- Kampmann, JP
- Article